Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis

MLA

Nishino, Mizuki, et al. “Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-Analysis.” JAMA Oncology, vol. 2, no. 12, Dec. 2016, pp. 1607–16. EBSCOhost, https://doi.org/10.1001/jamaoncol.2016.2453.

APA

Nishino, M., Giobbie-Hurder, A., Hatabu, H., Ramaiya, N. H., & Hodi, F. S. (2016). Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis. JAMA Oncology, 2(12), 1607–1616. https://doi.org/10.1001/jamaoncol.2016.2453

Chicago

Nishino, Mizuki, Anita Giobbie-Hurder, Hiroto Hatabu, Nikhil H. Ramaiya, and F. Stephen Hodi. 2016. “Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-Analysis.” JAMA Oncology 2 (12): 1607–16. doi:10.1001/jamaoncol.2016.2453.